Organization
Promomed
6 clinical trials
Clinical trial
Prospective Multicentre Comparative Randomized Double Blind Placebo Controlled Study of Safety and Efficacy of the Therapy With BRAINMAX® for the Treatment of Patients With Asthenia After Having the Novel Coronavirus Infection (COVID-19)Status: Completed, Estimated PCD: 2022-11-10
Clinical trial
Prospective Randomized Double Blind Placebo Controlled Study of Efficacy of the Therapy With BRAINMAX® Using Functional Magnetic Resonance Imaging (fMRI) for the Treatment of Patients With Post-COVID Asthenic SyndromeStatus: Completed, Estimated PCD: 2022-12-20
Clinical trial
Open Multicentre Study for Assessment of the Safety and Efficacy Against COVID-19 of the Drug JTBC00201 (PROMOMED RUS LLC, Russia) in the Adult PopulationStatus: Completed, Estimated PCD: 2022-06-01
Clinical trial
An Open-label, Multicentre, Randomized Comparative Study to Evaluate the Efficacy and Safety of Using the Sibutramin-containing Drugs Reduxin® Forte and Reduxin® in Patients With Alimentary ObesityStatus: Completed, Estimated PCD: 2021-05-21
Clinical trial
An Open Randomized Multicenter Comparative Study to Evaluate the Efficacy, Safety and Tolerability of the Use of Ambervin® for Intramuscular Administration and for Inhalation in Patients Hospitalized With COVID-19Status: Completed, Estimated PCD: 2022-11-22
Clinical trial
Double-Blind, Placebo-Controlled Multicentre Clinical Study for Efficacy and Safety Assessment of the Drug RADAMIN®VIRO for COVID-19 Postexposure ProphylaxisStatus: Completed, Estimated PCD: 2022-11-22